Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone (Q28371132)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone |
scientific article |
Statements
Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone (English)
Raza A
Qawi H
Lisak L
Andric T
Dar S
Andrews C
Venugopal P
Gezer S
Gregory S
Loew J
Robin E
Rifkin S
Hsu WT